TD Waterhouse Canada’s VanEck Biotech ETF BBH Stock Holding History

TD Waterhouse Canada’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-92	Closed	-$15.8K	–	2054
2025 Q3	$15.8K	Sell	92 -64,644	-100%	-$10.5M	﹤0.01%	1445
2025 Q2	$10M	Buy	64,736 +28	+0%	+$4.17K	0.07%	188
2025 Q1	$9.96M	Buy	64,708 +1,152	+2%	+$187K	0.08%	187
2024 Q4	$9.97M	Buy	+63,556	New	+$10.7M	0.08%	187
2023 Q4	–	Sell	-30	Closed	-$4.63K	–	1719
2023 Q3	$4.63K	Hold	30	–	–	﹤0.01%	1376
2023 Q2	$4.68K	Hold	30	–	–	﹤0.01%	1406
2023 Q1	$4.86K	Buy	+30	New	+$4.85K	﹤0.01%	1377

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.1B AUM 16.5% 1-Year Est. Return

TD Waterhouse Canada's BBH Position: Q4 2025 in Review

TD Waterhouse Canada sold out of VanEck Biotech ETF (BBH) in Q4 2025, closing a stake of 92 shares — an estimated $15.8K sold.

TD Waterhouse Canada first reported a position in BBH in Q1 2023 and held it in 7 quarters. The position peaked at $10M in Q2 2025. 111 funds tracked by Wall St. Rank hold BBH as of Q4 2025.

TD Waterhouse Canada reported no remaining VanEck Biotech ETF position as of Q4 2025 after selling out during the quarter.
TD Waterhouse Canada sold 92 VanEck Biotech ETF shares in Q4 2025, an estimated $15.8K.
TD Waterhouse Canada first reported a position in VanEck Biotech ETF in Q1 2023 and held it in 7 quarters.
TD Waterhouse Canada's VanEck Biotech ETF position peaked at $10M in Q2 2025.
111 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2025.

Based on TD Waterhouse Canada's 13F filing for Q4 2025, filed 27 Jan 2026.